Venetoclax demonstrated impressive efficacy in octogenarians with CLL, although treatment management posed some challenges.

According to recent statistics, Blacks are twice as likely to develop multiple myeloma as other ethnicities. To make matters worse, they also have a higher mortality rate when it comes to this form of ...